Start app

NervGen Pharma

NGEN · Biotechnology

Verified executive transcripts, quotes, and interview insights from NervGen Pharma leadership.

3
Executives Tracked
Search NervGen Pharma Data API Access
Mike Kelly
Mike Kelly
Former CEO
1 appearances
Adam Rogers
Adam Rogers
Chief Executive Officer
1 appearances
Rich Macary
Rich Macary
Board Advisor, Business Development and Strategy
1 appearances

About NervGen Pharma

Clinical-stage biotech developing NVG-291 for spinal cord injury. [BIOTECH-2026-10-04]

Access All NervGen Pharma Executive Data

Search transcripts, quotes, and verified statements from every NervGen Pharma executive via our platform or API.

Start Free Trial View Pricing